Hypotensive Activity and Toxicology of Constituents from Bombax ceiba Stem Bark(Pharmacology)
スポンサーリンク
概要
- 論文の詳細を見る
A novel constituent, shamimicin, 1''',1'''''''-bis-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3,7-dihydroxy-5-O-xylopy-ranosyloxy-2H-1-benzopyran alongwith lupeol, which possesses potent hypotensive activity has been isolated from Bombax ceiba stem bark. BCBMM-one of the most active hypotensive fractions has revealed its adverse effects on heart, liver and kidneys of mice at the dose of 1000 mg/kg/d.
- 2003-01-01
著者
-
SALEEM Rubeena
HMI Institute of Pharmacology and Herbal Sciences, Hamdard University
-
AHMAD Syed
HMI Institute of Pharmacology and Herbal Sciences, Hamdard University
-
AHMED Mohammad
HMI Institute of Pharmacology and Herbal Sciences, Hamdard University
-
FAIZI Zareen
Faizi Clinic
-
ZIKR-UR-REHMAN Sadia
HEJ Research Institute of Chemistry, University of Karachi
-
ALI Muhammad
HEJ Research Institute of Chemistry, University of Karachi
-
FAIZI Shaheen
HEJ Research Institute of Chemistry, University of Karachi
-
Ahmad Syed
Hmi Institute Of Pharmacology & Herbal Sciences Hamdard University
-
Faizi Zareen
Batool General Hospital
-
Ali Muhammad
Hmi Institute Of Pharmacology And Herbal Sciences Hamdard University
-
Faizi Shaheen
Hej Res. Inst. Of Chemistry International Center For Chemical Sciences Univ. Of Karachi
-
Faizi S
Hej Research Institute Of Chemistry International Center For Chemical Sciences University Of Karachi
-
Saleem Rubeena
Faculty Of Pharmacy Hamdard University:hmi Institute Of Pharmacology & Herbal Sciences Hamdard U
-
Ahmed M
Hmi Institute Of Pharmacology & Herbal Sciences Hamdard University
-
Zikrurrehman Sadia
Hej Research Institute Of Chemistry University Of Karachi
関連論文
- Hypotensive Activity and Toxicology of Constituents from Bombax ceiba Stem Bark(Pharmacology)
- Hypotensive Activity, Toxicology and Histopathology of Opuntioside-I and Methanolic Extract of Opuntia dillenii(Pharmacology)
- Analgesic and Antioxidant Activity of Mangiferin and Its Derivatives : the Structure Activity Relationship(Pharmacology)